肠球菌潜在风险——耐药基因储存库
Potential Risks of Enterococci—Reservoir of Drug-Resistant Genes
摘要: 肠球菌是一种广泛存在于自然环境中的乳酸菌(LAB),同时也可寄居于人和动物的肠道内。其被认为是引起院内感染的重要条件致病菌,可以引起尿路感染、脑膜炎、心内膜炎和脓毒血症等多种感染性疾病,且其发病率呈现出增高趋势。更重要的是,近年来研究表明,肠球菌可能是耐药基因的储存库,因其固有抗生素耐药性及其迅速获得额外抗生素耐药性的能力使感染很难治疗,尤其是万古霉素耐药菌的出现,构成了重大的感染控制负担。本文就肠球菌的致病性及耐药特性进行综述。
Abstract: Enterococci are ubiquitous lactic acid bacteria (LAB) that exist widely in the natural environment, and they can also reside in the gastrointestinal tract of humans and animals. They are considered as important opportunistic pathogen causing nosocomial infection, and can cause many infectious diseases such as urinary tract infection, meningitis, endocarditis and sepsis. Moreover, the incidence of infectious diseases caused by Enterococci shows an increasing trend. More importantly, studies in recent years have shown that enterococci may be a repository for drug resistance gene, as their inherent antibiotic resistance and their ability to rapidly acquire additional antibiotic resistance make infections much more difficult to treat, particularly the emergence of vancomcin-resistant bacteria, which constitutes a significant burden of infection control. The pathogenicity and drug resistance of enterococcus were reviewed in this paper.
文章引用:黄云飞. 肠球菌潜在风险——耐药基因储存库[J]. 微生物前沿, 2020, 9(3): 90-94. https://doi.org/10.12677/AMB.2020.93014

参考文献

[1] Agudelo Higuita, N.I. and Huycke, M.M. (2014) Enterococcal Disease, Epidemiology, and Implications for Treatment. In: Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Massachusetts Eye and Ear Infirmary, Boston.
[2] Top, J., et al. (2008) Emergence of CC17 Enterococcus faecium: From Commensal to Hospital-Adapted Pathogen. FEMS Immunology and Medical Microbiology, 52, 297-308. [Google Scholar] [CrossRef
[3] Franz, C.M.A.P., et al. (2001) Incidence of Virulence Factors and Antibiotic Resistance among Enterococci Isolated from Food. Applied and Environmental Microbiology, 67, 4385-4389. [Google Scholar] [CrossRef
[4] Ben Braiek, O. and Smaoui, S. (2019) Enterococci: Between Emerging Pathogens and Potential Probiotics. BioMed Research International, 2019, Article ID: 5938210. [Google Scholar] [CrossRef] [PubMed]
[5] AC, P. (2014) LPSN—List of Prokaryotic Names with Standing in Nomenclature. Nucleic Acids Research, 42, D613-D616. [Google Scholar] [CrossRef] [PubMed]
[6] Jin, D., et al. (2017) Enterococcus wangshanyuanii sp. nov., Isolated from Faeces of Yaks (Bos grunniens). International Journal of Systematic and Evolutionary Microbiology, 67, 5216-5221. [Google Scholar] [CrossRef] [PubMed]
[7] Kadri, Z., et al. (2015) Enterococcus bulliens sp. nov., a Novel Lactic Acid Bacterium Isolated from Camel Milk. Antonie Van Leeuwenhoek, 108, 1257-1265. [Google Scholar] [CrossRef] [PubMed]
[8] Shewmaker, P.L., et al. (2011) Reevaluation of the Taxonomic Status of Recently Described Species of Enterococcus: Evidence That E. thailandicus Is a Senior Subjective Synonym of “E. sanguinicola” and Confirmation of E. caccae as a Species Distinct from E. silesiacus. Journal of Clinical Microbiology, 49, 2676-2679. [Google Scholar] [CrossRef
[9] Harada, T., et al. (2016) Enterococcus saigonensis sp. nov., Isolated from Retail Chicken Meat and Liver. International Journal of Systematic and Evolutionary Microbiology, 66, 3779-3785. [Google Scholar] [CrossRef] [PubMed]
[10] Gao, W., Howden, B.P. and Stinear, T.P. (2018) Evolution of Virulence in Enterococcus faecium, a Hospital-Adapted Opportunistic Pathogen. Current Opinion in Microbiology, 41, 76-82. [Google Scholar] [CrossRef] [PubMed]
[11] Chiang, H., et al. (2017) Incidence and Outcomes Associated with Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis. Infection Control and Hospital Epidemiology, 38, 203-215. [Google Scholar] [CrossRef] [PubMed]
[12] 胡付品, 等. 2017年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2018, 18(3): 241-251.
[13] 胡付品, 等. 2016年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2017(5): 481-491.
[14] Jett, B.D., Huycke, M.M. and Gilmore, M.S. (1994) Virulence of Enterococci. Clinical Microbiology Reviews, 7, 462-478. [Google Scholar] [CrossRef
[15] Papa, M.F.D., et al. (2007) Full Activation of Enterococcus faecalis Gelatinase by a C-Terminal Proteolytic Cleavage. Journal of Bacteriology, 189, 8835-8843. [Google Scholar] [CrossRef
[16] Chajęcka-Wierzchowska, W., Zadernowska, A. and Łaniewska-Trokenheim, Ł. (2017) Virulence Factors of Enterococcus spp. Presented in Food. LWT, 75, 670-676. [Google Scholar] [CrossRef
[17] Araujo, T.F. and Ferreira, C.L.D.L.F. (2013) The Genus Enterococcus as Probiotic: Safety Concerns. Brazilian Archives of Biology and Technology, 56, 457-466. [Google Scholar] [CrossRef
[18] N, B.O., et al. (2004) Functional and Safety Aspects of Enterococci Isolated from Different Spanish Foods. Systematic and Applied Microbiology, 27, 118-130. [Google Scholar] [CrossRef] [PubMed]
[19] Franz, C.M.A.P., et al. (2011) Enterococci as Probiotics and Their Implications in Food Safety. International Journal of Food Microbiology, 151, 125-140. [Google Scholar] [CrossRef] [PubMed]
[20] Park, S.Y., et al. (2007) Extracellular Gelatinase of Enterococcus faecalis Destroys a Defense System in Insect Hemolymph and Human Serum. Infection and Immunity, 75, 1861-1869. [Google Scholar] [CrossRef
[21] Shankar, N., et al. (2001) Role of Enterococcus faecalis Surface Protein Esp in the Pathogenesis of Ascending Urinary Tract Infection. Infection and Immunity, 69, 4366-4372. [Google Scholar] [CrossRef
[22] Graham, K., Stack, H. and Rea, R. (2020) Safety, Beneficial and Technological Properties of Enterococci for Use in Functional Food Applications—A Review. Critical Reviews in Food Science and Nutrition, 1-26. [Google Scholar] [CrossRef] [PubMed]
[23] Moreno, M.R.F., et al. (2006) The Role and Application of Enterococci in Food and Health. International Journal of Food Microbiology, 106, 1-24. [Google Scholar] [CrossRef] [PubMed]
[24] Bondi, M., et al. (2020) Controversial Aspects Displayed by Enterococci: Probiotics or Pathogens? BioMed Research International. [Google Scholar] [CrossRef] [PubMed]
[25] Guzman Prieto, A.M., et al. (2016) Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones? Frontiers in Microbiology, 7, 788. [Google Scholar] [CrossRef] [PubMed]
[26] Courvalin, P. (2006) Vancomycin Resistance in Gram-Positive Cocci. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 42, S25-S34. [Google Scholar] [CrossRef] [PubMed]
[27] Xu, X., et al. (2010) vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium. Antimicrobial Agents and Chemotherapy, 54, 4643-4647. [Google Scholar] [CrossRef
[28] Lebreton, F., et al. (2011) D-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium. Antimicrobial Agents and Chemotherapy, 55, 4606-4612. [Google Scholar] [CrossRef
[29] Giraffa, G. (2002) Enterococci from Foods. FEMS Microbiology Reviews, 26, 163-171. [Google Scholar] [CrossRef] [PubMed]